[Therapy strategies in the prevention of chronic allograft nephropathy].
Chronic allograft nephropathy (CAN) is an anatomical and clinical alteration, characterized by proteinuria, hypertension and a progressive decline in kidney function, which begins at variable times (months, years) and can lead to the loss of the transplanted organ. CAN pathogenesis, which remains to be fully clarified, involves both immunological (early acute rejection, hyperimmunization, HLA-mismatches between donor and recipient, suboptimal immunosuppression, etc) and non-immunological factors (ischemia/reperfusion injury, reduced nephron mass, age differences between donor and recipient, dialysis time, hypertension, dislipidemia, proteinuria, etc). The possible prevention strategies for CAN consist of procedures aimed at the reduction of some potential risk factors: optimization of the conditions for organ explantation, diminution of ischemia/reperfusion injury, aggressive pharmacological treatment of acute rejection episodes, routine utilization of anti-hypertensive and hypolipidemic agents, and appropriate and rational immunosuppressive regimen. Moreover, some categories of immunosuppressive drugs, such as calcineurin inhibitors, can have a nephrotoxic effect, often regardless of therapeutic dosage. The introduction in clinical practice of novel immunosuppressive drugs with no nephrotoxicity, like mycophenolate mofetil and rapamycin, makes therapeutical strategies able to reduce the incidence of CAN feasible.
Scolari
M P
MP
Cattedra di Nefrologia, Centro Trapianti di Rene, Policlinico Universitario S. Orsola, Bologna - Italy. mpscolari@orsola-malpighi.med.unibo.it
Cappuccilli
M L
ML
Comai
G
G
Piccari
M
M
Ortolani
M
M
Conte
D
D
Lanci
N
N
Bianchi
F
F
Todeschini
P
P
Campieri
C
C
Stefoni
S
S
D002908:Chronic Disease; D006801:Humans; D007165:Immunosuppression Therapy; D007674:Kidney Diseases / Q000209:etiology* / Q000517:prevention & control*; D016030:Kidney Transplantation / Q000009:adverse effects*